Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70594-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin 01)

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
This is a prescription label for Daptomycin for Injection, a medication used for intravenous infusion. It contains 500mg of daptomycin per vial, and reconstitution instructions specify using 10 mL of 0.9% Sodium Chloride Injection to achieve a final concentration of 50 mg/mL. It is important to refrigerate the medication at a temperature range of 2°C to 8°C (36°F to 46°F) and to discard any unused portion of the solution. The product is manufactured by Xellia Pharmaceuticals USA, LLC and does not contain preservatives. It is essential to visually inspect the solution for particulate matter before administration. The label also advises using 0.9% Sodium Chloride Injection for reconstitution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.